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THIS investigation was undertaken to test the hypothesis that the body has a
defence mechanism against tumour invasion and spread, and that this defence
has failed in patients who die with widespread metastasis. The unpredictability
of tumour prognosis and the occasional case of undoubted spontaneous regression
of tumour (Stewart, 1952; Everson and Cole, 1956; Brunschwig, 1963) could be
explained by such a mechanism.
Although the antigenicity ofhuman tumours is still not absolutely proved there
is much evidence to suggest that certain malignant cells can act as antigens
(Southam and Moore, 1958), and experimental workers have definite evidence of
antigenic activity in many induced and spontaneous tumours in animals (Old and
Boyse, 1966; Klein, 1966; Baldwin, 1966; Hammond, Fisher and Rolley, 1967). It
therefore seems reasonable to assume that if a defence mechanism does exist it will
be, at least in part, immunological. It is impossible in retrospect (and at present
in prospect) to measure the antigenic power of a tumour but certain histological
appearances are known to be associated with immunological responses in experi-
mental animals (Scothorne and McGregor, 1955; Andre et al., 1962; Oort and
Turk, 1965) and have been observed in man in similar (but non-experimental)
conditions (Mellors, Brzosko and Sonskin, 1962; Mellors, Nowoslawski and
Korngold, 1961). In this study these features are accepted as possible evidence of
immunological reaction, and an attempt is made to assess the intensity of the
reaction from the degree of histological change. If these features reflect the
presence of an immunological reaction which acts as a defence mechanism, and the
histological appearances can be graded according to intensity, then the results
should have prognostic significance, provided that other factors which may
influence the immunological reactivity of the body remain the same.
Much work has been done on the prognostic significance of the grade of malig-
nancy of tumours based on the degree of differentiation, beginning with Broders'
studies of squamous cell carcinoma in 1920 (Broders, 1920, 1921, 1922). This
type of grading was applied to breast carcinoma by Greenough in 1925, Scarff in
1928 (Patey and Scarff, 1928) and later by Bloom in 1950. Bloom's grading of
breast carcinoma explains the rapid decline of those patients with small but
highly malignant undifferentiated tumours without axillary metastases, who die
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in the first few years after radical mastectomy, but it does not explain the appar-
ently paradoxical long survival of the patient who has a highly malignant
undifferentiated tumour with metastatic deposits in axillary nodes. Something
other than the grade of malignancy of the tumour must be invoked to explain
these contradictory findings. Again, metastases may manifest themselves at any
time up to 20 years or more after radical mastectomy. Clearly some factor
inhibits the growth of viable tumour cells for a variable length of time (Hadfield,
1954). One possible factor is host resistance.
Host resistance has been discussed in cancer literature for half a century
(Bashford, Murray and Cramer, 1908; Da Fano, 1910; Lambert and Haines, 1911;
Murphy and Morton, 1915; Mottram and Russ, 1917; Murphy and Taylor, 1918;
McArty and Mahle, 1921; Lumsden, 1925), and in 1946 Foote and Stewart
suggested that the lymphocytic infiltration of the stroma ofmedullary carcinoma
might represent a host reaction to the presence of tumour. A good prognosis is
now known to be associated with this type ofbreast carcinoma (Moore and Foote,
1949; Richardson, 1956), and long survival has been shown to be associated with
lymphocytic infiltration of the primary tumour and reactive changes in the
draining lymph nodes of breast and stomach carcinomata (Black, Kerpe and
Speer, 1953; Black, Opler and Speer, 1954, 1956). Recently the nature of the
resistance has been specified as probably immunological. It has been known for a
long time that the lymphoid system is the major tissue of reactivity to antigen
(McMaster and Hudack, 1935; McMaster and Kidd, 1937; Sabin, 1939; Harris and
Ehrich, 1945; Ehrich, 1945; Gyllensten, 1954) and since 1946 the plasma cell has
been known to be involved in the production of circulating antibodies (Fagraeus,
1946, 1948). Morerecently much ofthe mystery ofthefunction ofthelymphocyte
has been solved (Gowans and McGregor, 1965) and the immunological importance
of it and oflymph node activity has been demonstrated (Ada, Nossal and Austin,
1964; Gowans, 1965; Hanna, 1965; Baillif, 1966). Although histological appear-
ances can give no clue to the mechanism of a host defence reaction, the presence
ofhistological features associatedwithknownimmunological reactions ifcorrelated
with survival may be taken as presumptive evidence of an immunological reaction
which is functioning as a host defence.
Radical mastectomy specimens with the tumour and the regional lymph
nodes removed at one operation provide ideal pathological material for histo-
logical assessment of tumour and lymph node appearances and an analysis was
planned in which the grade oftumour malignancy and the intensity ofthe reaction
to the tumour, both in the breast and in the axillary lymph nodes, was recorded.
In order to present in numerical form an overall picture of the host defence
reaction, scores indicating the density of lymphocytes and plasma cells in and
around the tumour, and the intensity of the reaction in the nodes, were added
together, the scoring being done in such a way that a high score denoted an
intense reaction and vice versa. This score was then correlated with the grade of
malignancy of the tumour and the survival time. Other factors, such as clinical
stage, site of tumour, age of patient, etc. (de Cholnoky, 1943; Richards, 1948;
Nohrman, 1949; Handley and Thackray, 1954; Bloom and Richardson, 1957;
Treves and Holleb, 1958; Smithers and Payne, 1962) considered to influence
mortality and survival were also recorded and included in the final correlation, to
discover whether the presumptive immunological reaction had prognostic
significance in its own right.
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MATERIAL
In such an investigation as this it is essential to have no knowledge of the fate
of the patient when making the histological assessment of the tumour and the
nodes. The primary selection was therefore made on the basis of pathological
material available. All Royal Marsden Hospital (RMH) cases of radical mastec-
tomy carried out between 1935 and 1942 for which blocks were extant were
studied. Sections were cut and stained for histological assessment of the tumour
and lymph nodes (see under Methods). Unfortunately the clinical notes of at
least one third ofthe cases showed that the patients had been " lost to follow-up ".
To replace these lost cases, RMH radical mastectomy cases in 1943, 1944 and 1945,
for which it was known that there were complete clinical notes and paraffin blocks,
were added. Apart from this there was no consciousselectionofthe casesanalysed.
Ofthe total of 360 fully documented cases 20 cases had to be discarded because
irradiation had been given before radical mastectomy. Since irradiation produces
marked changes in lymph nodes any assessment made after irradiation could have
no value as an index of host reaction. A further 68 cases were excluded because
death had occurred within the 15-year follow-up period from diseases unrelated
to the breast carcinoma. Since this was a study of death or survival related to
certain histological features it was essential to know that when death occurred,
death was due to carcinoma. Finally 272 cases, either dying of carcinoma before
15 years or living for 15 years or more, remained for analysis.
METHODS
Grading of Intensity of " Host Defence Reaction
For each case blocks of the tumour and of the axillary nodes were recut and
new sections stained with methyl green-pyronin to demonstrate the presence of
plasma cells and other pyroninophilic cells.
Cellular infiltration around the tumour
The sections of the tumour were examined and the cellular infiltration around
the tumour was assessed under the following headings: (1) pattern and density of
infiltration, (2) density of plasma cell infiltration, (3) density of lymphocytic
infiltration, (4) presence of, and density of, large immature pyroninophilic
reticulum cells, sometimes called " immunoblasts " (Damashek, 1963; Mellors,
1966). Each factor was scored 0-3. Of these 4, only factor (1) requires further
explanation. Lymphocytic and plasma cell infiltration is frequently seen around
the periphery of the tumour but varies greatly in density and pattern. In some
tumours a wide zone of cellular infiltration surrounds the whole of the edge of the
tumour; in others only a few small collections of lymphocytes are present at
widely spaced intervals around the periphery, and, of course, all intermediate
stages are seen. The density of infiltration usually correlates with pattern but a
very thinly populated zone of cells completely surrounding the tumour is possible.
The patterns and densities were grouped and scored 0-3 (see below). Because
factors (2), (3), and (4) were qualifying factors of factor (1) all the scores were
added together and the average ofthe sum gave a possible final score offrom 0 to 3.
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Cellular infiltration of centre of the tumour
The cellular infiltration in the substance of the tumour was analysed on 2
factors only: (1) Density of lymphocytes, scored 0-3: (2) Density of plasma cells
and/or large pyroninophilic cells scored 0-3: in practice only plasma cells were
found in this position. The sums of (1) and (2) were averaged.
Lymph nodes
The appearances in the lymph nodes were analysed under the following
headings: (1) follicular hyperplasia, (2) reticulum cell hyperplasia, (3) plasma cells
in the medulla, (4) pyroninophilia of the large central cells of germinal centres,
(5) large pyroninophilic reticulum cells in cortex. The scores registered under
follicular hyperplasia and pyroninophilia of germinal centres ran parallel and so
(in 99 % of cases) did scores for (2) and (5). In both cases these scores were
averaged. Uninvaded nodes were used for this analysis where possible and
except for 6 cases enough nodal tissue remained even in invaded nodes, to
record the factors listed above.
Details of Coding Related to Scoring
Cellular infiltration around the tumour
(1) Pattern and density of infiltration Score
No focal areas of lymphocytic infiltration present, and only an
occasional lymphocyte or plasma cell seen (Fig. 1). 0
Small scattered focal areas of lymphocytic infiltration present or a
very thin entire zone of lymphocytes present (Fig. 2). 1
Numerous larger focal areas oflymphocytic infiltration present with
moderate number ofplasma cells, an occasional " immunoblast " or
one germinal centre (Fig. 3). 2
Entire zone of lymphocytes, plasma cells and pyroninophilic
reticulum cells surrounding the tumour or very numerous large
focal areas of lymphocytic infiltration with plasma cells and/or
germinal centres (Fig. 4, 5). 3
EXPLANATION OF PLATES
FIG. 1.-Edge of tumour showing sparse lymphocytic infiltration. x 25.
FIG. 2.-Edge oftumour showing small scattered focal areas oflymphocytic infiltration. x 25.
FIG. 3.-Edge of tumour showing numerous larger focal areas of lymphocytic infiltration.
x25.
FIG. 4.-Edge of tumour showing entire wide zone of lymphocytes and plasma cells. x 75.
FIG. 5.--High power ofcellularinfiltration present in Fig. 4 to show presence ofanimmunoblast.
x 300.
FIG. 6.--Centre of tumour with dense lymphocytic and plasmacytic infiltration of the stroma
between the groups of carcinoma cells. x 60.
FIG. 7.-High power of Fig. 6. x 250.
FIG. 8.-Portion of a lymph node in which no germinal centres were found. x 60.
FIG. 9.-Portion of a lymph node in which reactive changes were marked. x 60.
FIG. 10.-Pyroninophilic cell " immunoblast " in the cortex of a lymph node. x 250.
FIG. 11.-Well differentiated M+ (Bloom Grade I) carcinoma of breast. x 60.
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Score
(2) Plasma cells
(Numbers per High Power Field)
o 0
0*5-2 per HPF 1
3-10 per HPF 2
More than 10 per HPF 3
(3) Lymphocytic infiltration
Absent 0
Present + 1
Present ++ 2
Present +++ 3
(4) Pyroninophilic cells (other than plasma cells)
None seen 0
Up to 3 seen (especially in focal lymphocytic areas) 1
3-10 seen 2
More than 10, or a germinal centre showing marked
pyroninophilia 3
Cellular infiltration of centre of the tumour (Fig. 6, 7)
(1) Density of lymphocytes in the tumour
Absent 0
Present + 1
Present + 2
Present +++ 3
(2) Density ofplasma cells and pyroninophilic cells in the tumour
Absent 0
0.5-10 per HPF 1
10-20 per HPF 2
More than 20 per HPF 3
Lymph Nodes
(1) Follicular hyperplasia
Germinal centres absent (Fig. 8) 0
Germinal centres just recognisable 0-5
Germinal centres present + 1
Germinal centres present ++ 1*5
Germinal centres present +++ (Fig. 9). 2
(2) Reticulum cell hyperplasia
No reticulum cells seen 0
Very few reticulum cells present 0.5
Moderate number reticulum cells present 1
Numerous reticulum cells 2
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(3) Plasma cells in medulla and cortex Score
No plasma cells seen 0
Scanty plasma cells present 0.5
Moderate numbers in medulla, in perisinusoidal position 1
Numerous groups, or diffuse infiltration throughout node 2
(4) Pyroninophilia ofgerminal centres
Germinal centres absent 0
Few pyroninophilic cells 0o5
Germinal centres present, pyroninophilic cells + 1
Germinal centres present, pyroninophilic cells +-+ 1*5
Germinal centres present, pyroninophilic cells +++ 2
(5) Pyroninophilic cells (other than plasma cells) in pulp (Fig. 10).
No pyroninophilic cells seen 0
An occasional pyroninophilic reticulum cell present 0.5
Moderate number of pyroninophilic reticulum cells present 1
Numerous pyroninophilic reticulum cells present 2
The maximum possible final score for the periphery of the tumour is 3, for the
centre of the tumour is 3, and for the lymph nodes is 6. The maximum possible
total score is 12 and indicates the most intense reaction. This score of host
defence reaction (HDR) is used in shortened form in the tables and script as
D -, D+, and D+A- (see under Results).
Grading ofMalignancy of the Tumour
The grade of malignancy of the tumour was assessed on the histological
criteria laid down by Greenough (1925), Patey and Scarff (1928) and Bloom
(1950), but when correlated with mortality and drawn in graph form there was no
cleardivision inthis study ongrouping ofscores above 4. A two-grade malignancy
(M+ and M++) was therefore adopted in this series-those cases scoring 3 or 4
being put into the M+ grade (Fig. 11), i.e. almost equivalent to Grade I ofBloom,
and all scores higher than 4 into M++ grade; thus M+ grade includes all well-
differentiated tumours and M++ grade the moderately differentiated and
undifferentiated tumours.
Other Histological Features Recorded
These included the type of tumour, i.e. whether infiltrating carcinoma,
intraduct carcinoma, intralobular carcinoma or mucoid carcinoma, the presence of
mucin in tumour, the type of stroma supporting the tumour, e.g. fibrovascular
or dense collagen, the mast cell infiltration of the tumour and lymph nodes,
sinus histiocytosis of lymph nodes, scarring of sinusoids in lymph nodes, plasma
cell population ofgerminal centres ofnodes, plasma cell population ofsinusoids of
nodes, and presence or absence of metastatic tumour in nodes.
Other Data
When the histological analysis was complete the following data were recorded:
age, menopausal status, site and size of the tumour in breast, and clinical stage
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of the tumour (clinical staging was done afresh from the clinical notes using
standards of the current TNM method), details of irradiation therapy, and
whether alive or dead with date and cause of death.
RESULTS
All except one of the tumours were infiltrating carcinomata. The exception
was an intraduct carcinoma in the section available for study but since this
tumour measured between 3 and 5 cm. and the clinical stage was given as II it
was considered to be almost certainly infiltrating in some other area and the case
was not excluded. This patient was alive without recurrence at 16 years.
Mortality.-Of the 272 cases analysed and followed up, 91 were alive without
evidence of recurrence at 15 years; 31 .were dead at the end of the 1st year, 79 by
the end of the 2nd year. At the 5th anniversary of operation a total of 137 were
dead and by the 10th anniversary a further 35 had died, leaving 9 cases who died
between 10 and 15 years after operation.
HDF scores and D grading.-Analysis ofthe cases by HDF (see under Methods)
and mortality, gives the results presented in Fig. 12. The total scores are divided
into three groups:-
Group 1 HDF scores 0-4 Grade " D -" 102 cases
Group 2 HDF scores 4*25-575 Grade " D+" 110 cases
Group 3 HDF scores 6 and over Grade " D ++" 60 cases
Malignancy grading (M+ and M++).-Table I shows the cases divided by
malignancy grading (see under Methods).
TABLE I.-Survival According to Malignancy Grading
Alive at
Dead at 1 yr. 2 yrs. 3 yrs. 5 yrs. 7 yrs. 10 yrs. 15 yrs. 15 yrs. + Total
M+ . 2 . 6 . 4 . 7. 4 . 4 . 4 .30. 61
M+ + . 29 . 42 .20 .27. 15 .12 . 5 .61 .211
M and D gradings combined.--Analysis of 272 cases by both M and D grading
shows 61 M+ cases to be divided between the three D groups as follows: D- 34,
D+ 22, D++ 5. Since the D++ group was so small and the mortality figures
similar to those of the D+ it was decided to have two M+ groups:
M+D-= M scores 3 and 4 with D scores 0-4
M+D+ = M scores 3 and 4 with D scores above 4
In the 211 M++ cases i.e. those with M scores 5 and above, the three D groups
were retained. Thus the five MD grades are M++D-, M++D+, M++D++,
M+D -, M+D+. Table II gives the cases analysed by these grades and
correlated with mortality. InFig. 13 division ofthe 211 M++ casesby D grading
correlated with mortality is shown in graph form.
Nodal metastases.-In many studies ofbreast carcinoma the prognosis has been
shown to be greatly influenced by the presence or absence of axillary nodal
metastases and staging is an attempt to assess this situation clinically. Analysis
of the 272 cases shows axillary metastases present in 194 cases, and absent in 78
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No. of Cases DO.- 4 = 102
D4-'25-5 75 = 110
DOt = 60
Total 272
IDo -4
1D4*25 - 5-75
DO +
I a I U
5 7 10 15
YEARS
FIG. 12. Graph to show mortality after radical mastectomy of 272 cases
(M+ + and M+ grades) in three D grades.
(P < 0*05).
D 0-4 = D-grade
D 4-25-5-75 = D+ grade
D 6+ = D++ grade
TABLE II.-MD Grades and Mortality
2 yrs.
15
18
9
3
3
3 yrs.
8
8
4
3
1
5 yrs.
10
11
6
2
5
Alive at
7 yrs. 10 yrs. 15 yrs. 15 yrs. + Total
8 . 4 . 1 . 3 . 68
6 . 5 . 2 . 29 . 88
1 . 3 . 2 . 29 . 55
3 . 2 . 1 . 18 . 34
1 . 2 . 3 . 12 . 27
cases. Of the 194 cases with axillary metastases, 41 were alive 15 years or more,
121 were dead at the end of 5 years. Of the 78 cases without axillary metastases
50 were alive 15 years or more and only 16 were dead at the end of 5 years.
Clinical staging and nodal metastases.-When clinical staging is used as the
basis of analysis, 59 cases fall into Stage I, 76 into Stage II, 137 into Stage III.
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No. of Cases DO - 4 = 68
D4 25 - 5. 75 - 88
DO+ = 55
Total =-211
V 1 2 3 5 7 10 15
YEARS
FIGe. 13.-Graph to show mortality after radical mastectomy of 211 cases of
M+ + grade in three D grades
(P < 0 05)
D -4 = D-grade
D 4-25-5-75 = D+ grade
D 6+ = D+ + grade
36 Stage I cases, 32 Stage II cases and 23 Stage III cases were alive 15 years or
more after operation.
Histological evidence of metastasis was found in the lymph nodes from the
radical mastectomy specimens of 27 patients who had been staged clinically
Stage I; ofthese 27, 10 lived 15 years or more. In Stage II cases nodal metastases
were found in 53 cases of whom 17 lived 15 years or more, and were absent in 23
cases, 15 ofwhom lived 15 years or more. Of 114 Stage III casesshowingevidence
of nodal metastasis, only 14 cases lived 15 years or more; 23 cases were without
evidence of metastasis and 9 ofthese lived 15 years or more.
Clinical staging and MD grading.-Analysis of 211 M++ cases shows that of
35
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the 39 M++ cases in Stage I, 9 are D- grade, 22 are D+ grade and 8 are D++
grade. One of the 9 cases graded D- (11.1 %), 13 of the 22 D+ cases (59.09%)
and 7 ofthe 8 (87-5 %) D++ cases were alive at 15 years.
In Stages II and III similar trends in the figures are found. In Stage II 15
cases are D- grade and 1 was alive at 15 years (6.6 %); 24 cases are D+ grade and
10 were alive at 15 years (41.6%); 21 cases are DD++ and 11 were alive at 15
years (52.3 %). In Stage III 44 cases are D- grade, ofwhom only 1 was alive at
15 years (2.2 %); 42 cases are D+ with 6 alive at 15 years (14.2 %); 26 cases are
D++ with 11 alive at 15 years (42.3 %). Figure 14 gives in graph form the
mortality of 112 M++ Stage III cases divided by D grading. (P < or approx.
- to 0.05).
No. of Cases DO - 4 - 44
D4.25-5.75= 42
D6 + = 26
Total = 112
DO - 4
D4.25 - 5.75
DO +
E5.I
12 3 5 7 10 15
YEARS
FIG. 14.-Graph to show mortality after radical mastectomy of 112 Stage III cases
of M+ + grade in three D grades
(P < or approx. = to 0.05)
D 0-4 = D- grade
D 4-25-5-75 = D+ grade
D 6+ = D+ + grade
100*
90-
80-
70-
BO-
h 50-
40-
30-
20-
10-
i I I I
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Analysis of 61 M+ cases by staging and D grading gives the following 15-year
survival figures:
Stage I D 8 out of 10 cases alive 15 years.
D+ and D-+-+ 7 out of 10 cases alive 15 years.
Stage II D 7 out of 11 cases alive 15 years.
D+ and D++ 3 out of 5 cases alive 15 years.
Stage III D 3 out of 13 cases alive 15 years.
D+ and D-++ 2 out of 12 cases alive 15 years.
Clinical staying, MD grading and nodal metastases.-Additional analysis of
nodal metastases in Stages I, II and III gives the following 15-year survival
figures:-
Number alive 15 yrs, or more
+ve Nodes -ve Nodes
Stage I
M+ +D- . Olout of 3 0 out of 2
M++D+ .1 out of 8 I11 out of14
M++D+ + . 3 out of 6 6 out of 6
M+D- . 3 out of 4 3 out of 4
M+D+ . 3 out of 6 6 out of 6
Stage II
M+ +D- . 1 out of 11 No cases
M+ +D+ .5 out of 18 3 out of 6
M++D++ .6 out of 14 7 out of 10
M+D- . 2 out of 5 4 out of 4
M+D+ . 3 out of 6 2 out of 2
Stage III
M++D- .1 out of 29 0 out of 2
M+ +D+ . 4 out of 41 2 out of 7
M+ +D+ + . 7 out of 25 4 out of 8
M+D- I out of 7 1 out of 2
M+D+ . out of 12 2 out of 4
MenopaUsal status and 15-year survival.-The better prognosis ofthe patient in
the immediate premenopausal years has been shown by a number of authors
(Evans and Leucutia, 1939; Richards, 1948; Nohrman, 1949; Smithers and
Payne, 1962). Analysis of the 272 cases by menopausal status and mortality
confirmed these findings. Ninety-six patients were premenopausal; 41 lived 15
years or more without recurrence (42.7 %). Fifteen patients were recorded as
being menopausal; 6 lived 15 years or more (40 Of 131 post-menopausal
patients only 32 lived 15 years or more (24.4%).
Division ofthe cases into definite age groups gavethefollowing 15-year survival
figures: 33-3 % in the 30-39 age group, 37*1 % in the 40-44 age group, 47 % in the
45-49 age group, 31x2 % in the 50-59 age group, 20x5 % in the 60-69 age group and
29x4 % in the 70 and over age group. The highest 15-year survival figure occurs in
the 45-49 age group.
MD grade, menopausal statUs, age and 15-year survival.-Analysis ofthe figures
in each age group by MD grading shows that the proportion of cases in each MD
grade varies with the age group. In 45-49 age group only a small proportion
of cases fall into the M++D- grade which has such a poor prognosis. A high
proportion are in M++D+, and the rest divided evenly between the other three
grades M++D++, M+D-, M+D+. In the 5O-59 age group by far the largest
number are ofM++D- grade and ofthese only one was alive 15 years. In other
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age groups the division of the cases between the grades is intermediate between
these extremes.
The fifteen-year survival ofthe cases in the various grades in the different age
groups also varies; of 20 cases in M+ +D+ grade in the 45-49 age group 10 cases
lived 15 years or more (50 %), of 9 M++D+ cases in the 30-39 age group 2 lived
15 years (22.2 %). A similar lower 15-year survival figure is present in the 50-59
years group and 60-69 years group.
Table III attempts to present these variations in the six age group divisions.
TABLE III.-Fifteen Year Survival by Grades and Age Groups
Age Group
30 to 39 yrs.
MD Grades
* M±+D- M+±D+ M++D±± *M+ +D- M+ +D+ M+ D+ +
. A
B
C
D
E
40 to 44 yrs. . A
B
C
D
E
45 to 49 yrs. . A
B
C
D
E
50 to 59 yrs. . A
B
C
D
E
60 to 69 yrs. . A
B
C
D
E
70+ yrs. . A
B
C
D
E
4
19-0
0
0
0
6
17
0
0
0
5
9
1
20
1-9
29
36-2
1
3-4
1-3
17
25-5
1
5-8
1-4
8
47-0
0
0
0
9
42-3
2
22-2
9-5
12
34
5
41-2
14-2
20
39-2
10
50
19-6
21
26-2
5
24-0
6-2
22
32-3
5
23
7
3
17-1
2
66-6
11-7
3
14-2
2
66-6
9-5
6
17- 1
2
33-3
5-6
11
21-5
5
45-5
9-8
19
23-7
13
68-3
16-2
11
16- 1
4
36-3
5-8
5
29-3
3
60-0
17-8
% 15-yr.
, survival in
M+D- M+D+ age group
4
19-0
3
75
14-2
5
14-2
2
40
5-6
9
17-6
6
66-6
11-7
6
7-5
4
66-6
5
10
14-5
3
30
4-4
1
5-8
0
0
0
1
4-5
0
0
0
6
17-1
4
66-6
11-4
6
11-7
3
50
5
6-2
2
40
8
11-7
3
37-5
4-4
0
0
0
0
0
* A = Number of cases in each MD grade in each age group.
B Number of cases (A) expressed as % of total number of cases in age group.
C = Number of cases in each grade and age group alive 15 yrs. or more.
D = Number of cases alive 15 yrs. or more (C) expressed as a % of (A).
E = Number of cases alive (C) expressed as % of total cases in age group.
33-3
37-1
47-0
31-2
20-5
29-4
Post-operative irradiation and 15-year s?urvival.-One hundred and eighty four
patients received post-operative irradiation, 88 did not. Of the 184 patients,
44 lived 15 years (23-8 %) or more; 47 of the 88 patients lived 15 years or more
(53 3 %).
Post-operative irradiation, staging, nodal metastases and 15-year survival.-
Division of the cases by staging and post-operative irradiation shows an almost
equal division of 59 Stage I cases, 30 receiving irradiation. In Stage II, 51 cases
out of 76 received irradiation and in Stage III, 103 out of 137.
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Further analysis of these figures by nodal metastases shows that of the 27
with metastases in Stage I 16 received post-operative irradiation, 11 did not. Of
the 16 irradiated cases, 3 lived 15 years or more (18.7 %), ofthe 11 non-irradiated
cases, 7 lived 15 years or more (63.6 %). Fourteen cases in Stage I in which nodal
metastases were not found received irradiation, ofwhom 10 were alive 15 years or
more (68.5 %). Eighteen Stage I cases with negative nodes did not receive
irradiation; 16 of these were alive 15 years or more (88.8 %).
In Stages II and III a similar trend is evident (Tables IV, V).
TABLE IV.-Post-operattive Irradiation, Nodal Metastases and Survival in Stage II
Nodes DXR DXR Nodes DXR DXR
+ve given not given -ve given not given
54 .39 15 . .22 .12 . 10
Alive 15 yrs.± . 17 . 12 . 5 Alive 15 yrs.+ . 16 . 7 . 9
% alive 15 yrs. + 31-4 . 30-8 . 33-3 . % alive 15 yrs. + 72-2 59-3 . 90
TABLE V.-Post-operative Irradiation, Nodal Metastases and Survival in Stage III
Nodes DXR DXR Nodes DXR DXR
+ve given not given -ve given not given
114 .90 . 24 . .23 .13 . 10
Alive 15 yrs. + .14 .9 . 5 .Alive 15 yrs. + .9 .4 . 5
% alive 15 yrs.± . 12-2. 10 . 20-8 . % alive 15 yrs. + . 391 37-6. 50
Post-operative irradiation, staging, nodal metastases, MD grading and 15-year
survival.-When the figures given above under staging, nodal metastases, and
MD grading, are further divided into those receiving and not receiving post-
operative irradiation, the following figures are obtained:-
Stage I M++D- The 5 patients in M++D- grade were dead before 15
years. Four received irradiation, 2 of these having
invaded nodes.
M++D+ Seven patients with nodal metastases receiving irradiation
diedbefore 10 years.
One patient not receiving DXR lived over 15 years.
Of 14 patients with negative nodes, 5 received irradiation
and 9 did not. Four of those receiving irradiation and
7 of those who did not receive irradiation lived more than
15 years.
M++D ++ Six patients with nodal metastases. Five received irradia-
tion and 2 of these lived 15 years; 1 did not and was alive
after 15 years. In 6 patients the nodes were free of
metasteses, 2 received irradiation: all 6 lived.
M+D- Eight patients, 4 with nodal metastases, 4 without. Two
of each group received irradiation. All 4 which did not
receive irradiation lived 15 years or more. One with
invaded nodes and one with uninvaded nodes given
irradiation lived 15 years or more.
M+D + Six patients with nodal metastases were not given irradia-
tion, 3 lived 15 years or more. Six patients without nodal
metastases, 3 received irradiation, all 6 were alive at 15
years.
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TABLE VI.-Post-operative Irradiation, Nodal Metastases, MD grading and
Survival in Stage II
MD Grade
M+ +D-
M+ +D+
M+ +D+ +
M+D-
M+D+
Nodes
+ve
11
18
14
6
6
DXR
given
10
12
11
2
4
Alive DXR Alive
15 not 15 Nodes
yrs. + given yrs. + -ve
.1 .1 .0
. 4 . 6 . 1 . 6
. 4 . 3 2 . 10
.1 .3 . 1 . 4
.2 .2 .1 . 2
Alive
DXR 15
given yrs. +
5 .2
3 . 1
3 .3
1 .1
DXR
not
given
Alive
15
yrs. +
.7.6
. 1 . 1 . 1 . 1
TABLE VII.-Post-operative Irradiation, NodalMetastases, MD grading and
Survival in Stage III
Alive DXR Alive Alive DXR Al
Nodes DXR 15 not 15 Nodes DXR 15 not I
lID Grade +ve given yrs. + given yrs. + -ve given yrs. + given yrs
+D- .29 .25 .1 .4 .0 2 .1 .0 .1 .(
+D+ . 41 .29 . 1 .12 .3 . 7 .4 . 1 .3 .
+D+± . 25 . 19 . 5 . 6 . 2 8 . 4 . 2 . 4
D- . 7 . 7 .1 .0 .0 . 2 .2 .1 .0 .(
D+ . 12 .10 .1 .2 .0 4 .2 .0 .2 .
live
15
+
0
1
2
0
2
Tumours ofinner quadrants.-Comparison ofinner and outer quadrant tumours
shows a higher mortality with a larger number of deaths in the early years in
Stages II and III tumours ofthe inner quadrants. In Stage I the 15-year survival
figures are lower in inner quadrant tumours. The incidence of post-operative
irradiation is higher for inner quadrant tumours, but the 15-year survival figures
are similar in both inner and outer quadrant tumour cases when irradiation was
given, viz. 20 %. The 15-year survival figure of non-irradiated outer quandrant
tumours is considerably higher than that of the non-irradiated inner quadrant
tumours. The distribution of the MD grades is similar in both groups and the
incidence of positive nodes in the patients who lived 15 years is approximately
the same.
TABLE VIII.-Comparative Survivalfor Patients with Tumours of the Inner
and Outer Quadrants
Inner Quadrants
Alive 15 yrs.
Stage DXR+ DXR- DXR+ DXR- Total
I 6 5 2 4 11
II . 16 5 6 2 21
III .25 9 2 1 34
47 19 10 7 66
Percentage surviving 15 years 25-1
Percentage of cases receiving irradiation 71
Percentage 15-year survival of patients
receiving irradiation 21
Percentage 15-year survival of patients not
receiving irradiation 48 1
Outer Quadrants
, ~~~~~A
DXR+
18
33
60
111
Alive 15 yrs.
DXR- DXR+ DXR-
22 8 17
15 6 9
18 9 8
55 23 34
Other data recorded (see under Methods)
Mucin production in the tumour.-No tumours were entirely of the " colloid ".
type though areas of " mucoid degeneration " were evident in some tumours.
Total
40
48
78
166
34-3
60-8
20-7
61-8
396
1.
M+
M+
M+
M+.
M+.HOST RESISTANCE IN BREAST CANCER
The presence ofmucin was found to correlate closely with the differentiation ofthe
tumour.
Type ofstroma. The type ofstroma supporting the tumour varied from a loose
fibrovascular stroma to dense collagenous fibrous tissue. Correlation of these
variations with mortality showed a higher mortality in the cases having a dense
collagenous stroma. When related to the components of the HDR score it was
found that the density oflymphocytic and/or plasma cell infiltration ofthe stroma
at the centre of the tumour was greater when the stroma was of the loose fibro-
vascular type.
Mast cell infiltration of tumour and lymph nodes.-There was considerable
variation in the density ofthe mast cell population around the edges ofthe tumours
and in the lymph nodes but no evidence of correlation with mortality could be
found.
Sinus histiocytosis of lymph nodes. (Black and Speer, 1958; Berg, 1956). A
distinct correlation was present between the presence of marked sinus histio-
cytosis and good survival when uninvaded lymph nodes were available for study.
Scarring ofsinuses in lymph nodes.-Obliteration ofperipheral sinuses oflymph
nodes by fibrous tissue is not uncommon in nodes from radical mastectomy
specimens. No apparent correlation with mortality could be demonstrated.
Plasma cell population of germinal centres of nodes.-Plasma cells were rarely
found within the germinal centres in this study.
Plasma cellpopulation ofsinuses oflymph nodes.-No correlation with mortality
could be demonstrated in this study.
Size of tumour.-No clear pattern of correlation could be found between size
oftumour and mortality, though the majority ofthe better prognosis Stage I cases
had small tumours. In the group of larger tumours, however, some died within
2 years of radical mastectomy; others lived 15 years. The larger tumours when
associated with agood prognosis were found to beM++D + orM++D++ grade.
DISCUSSION OF RESULTS
Mortality and survival.-This was a study of death or survival related to
certain histological features present in the tumour and lymph nodes. Patients
who died before the 15th anniversary of the radical mastectomy of causes other
than carcinoma of the breast were excluded, as were patients in whom the cause
of death was not certain. No case was included for which complete follow-up was
not available and since the patients who lived 10 or more years were consistently
well-documented, this series includes a relatively large number of patients who
survived 15 years (91 out of 272).
HDR scores, D grading, M grading and Mortality.-Figure 12 shows the
mortality curves of the three D grades resulting from grouping of the HDF
scores, the D- grade being those with the lowest score, and D ++ grade those
with the highest HDF score. The 95 % confidence limits for each curve are also
shown and after the fifth year the mortality curves differ significantly from each
other (P < 0.05).
In Table I the results of the modified Bloom malignancy grading of breast
carcinoma are given and the relatively good prognosis of the well-differentiated
carcinoma (M+ grade) noted by Bloom is confirmed here. The HDR score
associated with these tumours is usually low and therefore these tumours fall into
the D- grade. In Figure 12 34 M+ grade cases are included in the D- grade
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group. Figure 13 shows the mortality curves of M ++ cases only and here the
curves for the three D grades are significantly different throughout the period
studied (P <0.05). The lymphoid stroma ofthe medullary carcinoma contributes
to a high HDR score and of the 55 tumours in the M ++D++ grade, 28 were
classifiable as medullary carcinomata. Of these 15 lived 15 years or more,
confirming in this series the good prognosis of this type of poorly differentiated
carcinoma. In Table II the details ofmortality and survival ofthe cases divided
into 5 MD grades are given. The figures of the M+DA- and M+D + grades,
though small, suggest that the HDR has little influence on the survival of a
patient with a well-differentiated carcinoma, a 50% (approx.) 15-year survival
being present in the figures of both D- and D+ grades. This is in sharp contrast
to the other three grades M++D -, M++D + and M++D++ where the
15-year percentage survival is 4-4, 32-9 and 52 respectively (see Fig. 13). Clearly
the D grading has a marked effect on the prognosis of cases with poorly
differentiated M + + grade carcinomata of breast.
Clinical staging, nodal metastases and MD grading.-The incidence of nodal
metastasis is closely related to prognosis. Clinical staging and prognosis
also show a close relationship and some correlation is present between clinical
staging and nodal metastasis but even the combination of these leaves some
Stage I patients without nodal metastases who die early and some Stage III
patients with nodal metastases who live 15 years. MD grading added to the
divisions made by clinical staging and nodal metastasis, explains the apparent
paradoxes. Stage I tumours of M ++ grade may have a prognosis as good as
that of a M + grade tumour if the HDR gives a D ++ grade score whether the
nodes are invaded or not. If the nodes are free of metastases a similar good
prognosis may be associated with a HDR score of D + grade. The relatively
good prognosis of the patient with a Stage III M ++D++ tumour is shown in
Fig. 14 where the mortality curves of 112 Stage III M+ + cases are given. In
this series many patients with Stage III tumours in the MA++D ++ grade with
invaded nodes had a better prognosis than patients with Stage I or II tumours in
the M++D- grade.
From the figures given in Results it is clear that staging is to a certain extent
a clinical measure of the MD grading. Few M++D - cases present as Stage I
cases.
MD Grading, Menopausal Status, Age and 15-year Survival.-The better
prognosis of the patient diagnosed in the immediate premenopausal years is an
interesting observation. The poor prognosis of the patient developing carcinoma
under the age of 35 years has been argued by many authors (Treves and Holleb,
1958; de Cholnoky, 1943). In this study the results suggest the the younger age
group does not have a poorer prognosis than the average patient with carcinoma
of the breast. This group has a prognosis similar to all groups other than those
in the immediate premenopausal age group, which has a better prognosis than the
rest. The analysis presented in Table III attempts to show that in the immediate
premenopausal years the distribution of the MD grades is different from other age
periods. Fewer cases fall into the poor prognosis MA++DA- grade and more into
the good prognosis M +A+D ++ grade. Furthermore, in this series, the 15-year
survival figures for each grade, including the MA++D - grade are better in this
premenopausal age group than at any other time of life. These figures are small
and, of course, not significant statistically but it is an interesting trend which
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is consistent and goes some way to explaining the better prognosis enjoyed by
patients developing carcinoma of the breast in this age group. It does not, of
course, in any way explain the increased HDR nor the apparently increased
effectiveness of the HDR.
Post-operative irradiation, staging, nodal metastases and MD grading.-From
an examination of the figures given in this section of Results it is clear that the
decision to give or withhold irradiation was not based entirely on staging or the
presence or absence of nodal metastases. Naturally these patients were treated
by anumber ofsurgeons and no doubt their views on treatment ofbreast carcinoma
varied considerably. An analysis of the proportion of patients with carcinoma
ofthe breast treated with irradiation at RMH during the years 1935-43 inclusive,
shows a marked increase from 38 % in 1935 to 82 % in 1941, dropping back to 70 00
in 1942 and 1943. This suggests that the popularity of the treatment was an
important factor in the decision in the later years, rather than the clinical stage or
presence of nodal metastases.
The figures given in Results show a trend which suggests that post-operative
irradiation does not improve the prognosis in any group of cases and may, in fact,
be associated with poorer survival figures.
When these figures are taken in conjunction with MD grading the possibility
that irradiation may reduce the HDR and thus worsen the prognosis is suggested
by the poorer survival ofthe irradiated cases in comparable groups. Again these
figures are very small and cannot be considered significant but it is interesting
that the trend should be present and should be consistent in all stages and grades.
Tumours of the inner quadrants.-The poorer prognosis of inner quadrant
tumours is well documented. Handley and Thackray (1954) found the presence
of metastases in the internal mammary nodes to be three times more frequent
with inner quadrant tumours than with outer quadrant tumours. In the present
series inner quadrant tumours had a 15-year survival of25 1 % and outer quadrant
tumours 34-3 %. The distribution of the MD grades was more or less the same,
but in each comparable grade and stage the percentage 15-year survival was less
in the inner quadrant group, although the percentage survival did improve as the
HDR score rose. Thus the poorer prognosis cannot be explained by differences in
MD grading.
A slightly larger proportion of patients with inner quadrant tumours received
irradiation but the percentage 15-year survival was the same in the two groups.
When irradiation was not given the 15-year survival in the outer quadrant tumour
patients was higher by 13 %.
GENERAL DISCUSSION
The histological appearances described in this study cannot be accepted as
proof of either the existence of an immunological defence, or of its intensity,
though there is now much experimental support for such an interpretation.
Nevertheless, there is no doubt ofthe close correlation between the intensity ofthe
histological changes described, and prognosis. Furthermore this correlation is
largely independent ofother factors hitherto regarded as ofprognostic significance
and accounts for many of the apparently paradoxical situations encountered
clinically.
The relationship of the histological changes (HDR) to nodal metastasis is
interesting. The tumours of high grade malignancy (M++) with low scoring
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HDR (D-) were almost invariably associated withthepresenceofnodalmetastases
and in this group of cases the clinical state of the axillary nodes is a good index of
prognosis. However, the presence ofaxillary nodal metastases is notincompatible
with a high HDR score and a long survival. The long survival without recurrence
of this last group of patients may perhaps be considered an argument in favour
of the continuation of radical mastectomy as the operation of choice.
The different distribution of the MD grades in the various age groups and the
association of a lower incidence of the poor prognosis M++D- grade tumour
in the immediate premenopausal patient does help to explain the lower mortality
of this group as opposed to other age groups, both older and younger.
The depressant effect of irradiation on the function of the lymphoid system
and the circulating lymphocyte count has been known almost since irradiation was
first used (Hektoen, 1915, 1918). If the HDR as recorded in this investigation
does, in fact, reflect an immunological reaction to the tumour then the consistently
poorer survival of those patients receiving post-operative irradiation may be
partially the result of depression of the immunological reaction manifested by the
HDR. Bond (reported in World Medicine Oct. 17, 1967) has stated that post-
operative irradiation does not increase the survival time of patients with nodal
metastases, and may, in fact, shorten the survival period of patients without
nodal metastases. The figures presented in this series show a similar trend.
SUMMARY
A method ofgrading breast carcinoma, based upon the histological appearance
of the tumour and the host defence reaction to it, is presented. This grading is
shown to correlate closely with prognosis.
The relationship of this grading to clinical staging, nodal metastasis, age,
menopausal status, and to prognosis is discussed.
The possible effect of irradiation upon a host defence reaction, which is mani-
fested by histological appearances known to be associated with immunological
reactions, is discussed.
The evidence presented supports the hypothesis that the prognosis of a patient
with carcinoma of the breast is dependent on the host's reaction to the tumour as
well as the grade of malignancy of the tumour.
I am very grateful to Mr. M. D. Staunton F.R.C.S. who helped me with the
clinical details and restaged all the cases.
I also wish to thank Miss Ruth Bell for help with the statistics, Mr. C. H.
Chadwin for technical help, the Medical Arts Department for preparation of the
graphs and Mrs. M. Barry for the preparation of the photographs.
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